NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2020
CVR: 24257908
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -31,604 and a net result of DKK 2,470,893 compared with DKK -31,506 the year before. Equity in the 2020 report amounted to DKK 28,837,017. The solvency ratio was 91.3%.
- Gross Profit
- DKK -31,604
- Profit/Loss
- DKK 2,470,893
- Equity
- DKK 28,837,017
- Total Assets
- DKK 31,588,951
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -32K | 2.5M | 28.8M | 0 |
| 2019 | - | -38K | -32K | 26.4M | 0 |
| 2018 | - | -58K | -4.8M | 26.4M | - |
| 2017 | - | -74K | -5.4M | 1.2M | - |
| 2016 | - | -78K | 254K | 6.6M | - |
Official annual report
How creditworthy is NOVOZYMES BIOINDUSTRIAL A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2019. Gross profit came to DKK -37,567, and the net result was DKK -31,506.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.